$ABCL
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Healthcare
Sector
Biotechnology
Industry
Carl Hansen
CEO
596
Employees
$3.40
Current Price
$963.86M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 2 | 3 | $856,696.39 | 258,057 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 2 | 3 | $856,696.39 | 258,057 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 2 | 3 | $856,696.39 | 258,057 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Thermopylae Holdings Ltd. 10% Owner | Purchase | 38,000 | $3.44 | $130,720.00 | View Details |
| Feb 26, 2026 | Thermopylae Holdings Ltd. 10% Owner | Purchase | 177,457 | $3.27 | $580,284.39 | View Details |
| Feb 27, 2026 | Booth Andrew Chief Financial Officer | Purchase | 42,600 | $3.42 | $145,692.00 | View Details |
1 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.20
ActualN/A
Revenue
Estimated$5.68M
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated-$0.16
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.18
Actual-$0.03
Beat
Revenue
Estimated$16.71M
Actual$44.85M
Beat
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals